The
Regensburg-based digital health startup brainjo has closed a €2 million seed
funding round, led by High-Tech Gründerfonds (HTGF), with additional
participation from strategic partners and business angels, including Andreas
Weinhut (Regensburg) and better ventures.
Limited
therapy availability, long waiting lists, and insufficient access to mental
health services continue to challenge healthcare systems. brainjo aims to
address these gaps by leveraging Virtual Reality (VR) as a prescribable
extension to psychotherapy, designed to enhance patient adherence and
accessibility.
The
company develops Digital Health Applications (DiGA) that can be prescribed by
therapists or physicians and reimbursed by health insurance. Rather than
replacing traditional psychotherapy, these immersive VR-based solutions
complement existing treatments by offering individualised and accessible
therapy that patients can utilize from home.
This
approach assists bridge critical gaps in care where conventional therapy alone
may fall short.
Markus Wensauer, co-founder and CEO of brainjo, commented:
With a
strong network of business angels, MEDICE – The Health Family as a strategic
partner, and HTGF as a leading European seed investor, we are ideally
positioned to bring our solutions into healthcare and establish multimodal
therapy offerings for patients.
The
company’s mission is to create evidence-based, immersive therapy solutions that
complement and scale existing treatment approaches.
The
newly secured capital will finance the next major milestone: a clinical study
and the regulatory approval of brainjo’s first VR-based DiGA. This initial
application, focutilized on children with ADHD, is being developed in collaboration
with MEDICE – The Health Family. Market approval is currently planned for 2028.
Leave a Reply